Article PDF
References
Dulin WE, Wyse BM, Kalamazoo MS (1969) Studies on the ability of compounds to block the diabetogenic activity of streptozotocin. Diabetes 18:459–466
Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarui S (1982) Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. Diabetes 31:749–753
Yonemura Y, Takishima T, Miwa K, Miyazadi I, Yamamota H, Okamoto H (1984) Amelioration of diabetes mellitus in partially depancreatized rats by poly (ADP-ribose) synthetase inhibitors. Diabetes 33: 401–404.
Sandler S, Andersson A, Korsgren O et al. (1986) Tissue culture of human fetal pancreas. Effects of nicotinamide on insulin production and formation of islet like cell clusters. Diabetes 38 [Suppl 1]: 168–171
Mandrup-Poulsen T, Helqvist S, Wogensen LD et al. (1990) Cytokines and free radicals as effector molecules in the destruction of the pancreatic β-cells. Curr Top Microbiol Immunol 164: 169–193
Rankin PW, Jacobsen EL, Benjamin RC, Moss J, Jacobsen MK (1989) Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. J Biol Chem 264: 4312–4317
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pociot, F., Reimers, J.I. & Andersen, H.U. Nicotinamide — biological actions and therapeutic potential in diabetes prevention. Diabetologia 36, 574–576 (1993). https://doi.org/10.1007/BF02743277
Issue Date:
DOI: https://doi.org/10.1007/BF02743277